Related Experiment Video
Updated: Jan 7, 2026

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
SF3B1K700E rewires splicing of cell cycle regulators
Mai Baker1,2, Eden Engel3,4, Aveksha Sharma3
1Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel mib.sal89@gmail.com maayan.salton@mail.huji.ac.il.
Mutations in SF3B1 (a spliceosome component) disrupt RNA splicing, affecting cell cycle control and promoting cancer. The SF3B1K700E mutation specifically alters splicing of G2/M regulators like ARPP19, impacting cell division and patient survival.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Pre-mRNA splicing is vital for cellular homeostasis and tightly regulated, especially for cell cycle progression.
- SF3B1, a spliceosome component, is crucial for alternative splicing and frequently mutated in cancers.
- The SF3B1K700E mutation disrupts splicing and cell cycle control, contributing to tumorigenesis.
Purpose of the Study:
- To investigate the impact of SF3B1K700E mutation on RNA splicing patterns.
- To identify splicing alterations linked to the SF3B1K700E mutation and their functional consequences.
- To explore the relationship between SF3B1-dependent splicing, cell cycle regulation, and cancer development.
Main Methods:
- RNA sequencing (RNA-seq) of K562 erythroleukaemia cells expressing wild-type or SF3B1K700E.
- siRNA-mediated depletion of SF3B1 in HeLa cells to validate mutation-dependent splicing signatures.
- Pharmacological inhibition of DYRK1A and serine/threonine phosphatases.
- Functional assays including ectopic expression of ARPP19-long isoform.
- Analysis of TCGA-AML cohort data.
Main Results:
- Identified 763 high-confidence splicing alterations in SF3B1K700E cells, enriched for G2/M regulators (e.g., ARPP19, ENSA, STAG2, ECT2).
- Increased inclusion of ARPP19 exon 2 leads to ARPP19-long isoform, inhibiting PP2A-B55 and promoting mitosis.
- A subset of SF3B1K700E-linked splicing changes were observed upon SF3B1 depletion, indicating a mutation-specific spliceosomal signature.
- Kinase-phosphatase signaling (DYRK1A, phosphatases) influences ARPP19 exon 2 inclusion.
- Ectopic ARPP19-long expression accelerated mitotic exit; high ARPP19-long levels correlated with poorer survival in AML patients.
Conclusions:
- SF3B1K700E mutation drives specific splicing alterations impacting cell cycle regulators.
- The ARPP19-long isoform plays a role in mitotic progression and is linked to adverse outcomes in AML.
- SF3B1-dependent splicing dysregulation is a key mechanism in cancer development, offering potential therapeutic targets.
Related Concept Videos
Restarting Stalled Replication Forks
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System
Negative Regulator Molecules
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Methods of Nuclear Reprogramming

